- Home
- GPCR vs VRTS Comparison
GPCR vs VRTS Comparison
Compare GPCR & VRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- VRTS
- Stock Information
- Founded
- GPCR 2016
- VRTS 1988
- Country
- GPCR United States
- VRTS United States
- Employees
- GPCR N/A
- VRTS N/A
- Industry
- GPCR
- VRTS Investment Managers
- Sector
- GPCR
- VRTS Finance
- Exchange
- GPCR Nasdaq
- VRTS Nasdaq
- Market Cap
- GPCR 1.8B
- VRTS 1.4B
- IPO Year
- GPCR 2023
- VRTS 1992
- Fundamental
- Price
- GPCR $40.36
- VRTS $205.68
- Analyst Decision
- GPCR Buy
- VRTS Hold
- Analyst Count
- GPCR 6
- VRTS 4
- Target Price
- GPCR $81.33
- VRTS $231.25
- AVG Volume (30 Days)
- GPCR 593.8K
- VRTS 30.1K
- Earning Date
- GPCR 08-08-2024
- VRTS 10-25-2024
- Dividend Yield
- GPCR N/A
- VRTS 4.41%
- EPS Growth
- GPCR N/A
- VRTS N/A
- EPS
- GPCR N/A
- VRTS 14.95
- Revenue
- GPCR N/A
- VRTS $880,284,000.00
- Revenue This Year
- GPCR N/A
- VRTS N/A
- Revenue Next Year
- GPCR N/A
- VRTS $3.48
- P/E Ratio
- GPCR N/A
- VRTS $13.65
- Revenue Growth
- GPCR N/A
- VRTS 7.35
- 52 Week Low
- GPCR $26.61
- VRTS $168.78
- 52 Week High
- GPCR $75.02
- VRTS $263.39
- Technical
- Relative Strength Index (RSI)
- GPCR 57.92
- VRTS 47.96
- Support Level
- GPCR $38.27
- VRTS $190.42
- Resistance Level
- GPCR $42.67
- VRTS $212.08
- Average True Range (ATR)
- GPCR 2.29
- VRTS 4.73
- MACD
- GPCR 0.31
- VRTS -0.03
- Stochastic Oscillator
- GPCR 76.72
- VRTS 45.14
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
About VRTS Virtus Investment Partners Inc.
Virtus Investment Partners Inc provides investment management and related services to individuals and institutions. Its retail products include open-end mutual funds, closed-end funds, exchange-traded funds, and variable insurance funds. Geographically, the activities are carried out through the region of the U.S. and the group generates revenue through investment management fees, distribution and service fees and administration and shareholder service fees.